ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activitiesZURICH, ...

(Juan Gartner/Science Photo Library/Getty Images) The human immune system has evolved an incredible ability to fight off ...

When you’re living with extensive-stage small-cell lung cancer (ES-SCLC), your first treatment to slow the disease from worsening may be pretty different from your second. One key thing to know is ...

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Imagine that two women have breast cancer with the same subtype: hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-). They’re the same age, weight, and height ...

Scientists have identified a molecular switch that may help explain how colorectal cancer becomes deadly. When levels of a ...

Safety and efficacy of a small-molecule c-Myc degrader WBC100 in solid tumors: A first-in-human, phase I trial. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

Dandelion root extract has shown remarkable potential in laboratory tests against colorectal cancer cells, triggering programmed cell death through multiple pathways. This multi-target approach is ...